Moneycontrol PRO
HomeAuthorR. sree ram

R. Sree Ram

News Editor

Moneycontrol

Moneycontrol Pro Panorama | Indian investors are getting cosy with risk 

BUSINESS

Moneycontrol Pro Panorama | Indian investors are getting cosy with risk 

In this edition of Moneycontrol Pro Panorama: India’s power demand ramps up dramatically, delayed NHAI projects cause for concern, mastering AI tools a useful skill, markets find RBI’s liquidity policy difficult, and more

Chart of the Day: India’s peak power demand rises at fastest pace in over a decade

BUSINESS

Chart of the Day: India’s peak power demand rises at fastest pace in over a decade

Peak electricity demand grew at an average annual rate of 6.7 percent between 2019 and 2023, higher than 5.3 percent in the previous four years

Moneycontrol Pro Panorama | Uday Kotak is not riding into the sunset anytime soon

BUSINESS

Moneycontrol Pro Panorama | Uday Kotak is not riding into the sunset anytime soon

In today's edition of Moneycontrol Pro Panorama: Indian foreign policy needs a rejig, high demand for MGNREGA signals a job crunch, no takers for dollar, slow bank credit no reason to worry, and more

Chart of the Day: Falling fertiliser prices to lighten government subsidy bill

BUSINESS

Chart of the Day: Falling fertiliser prices to lighten government subsidy bill

Price of widely used urea dropped 52.7 percent in June 2023 quarter 

Moneycontrol Pro Panorama | Pharma investors should not ignore risks in US market

BUSINESS

Moneycontrol Pro Panorama | Pharma investors should not ignore risks in US market

In today's edition of Moneycontrol Pro Panorama: Strong services sector growth highlights momentum, how to make sense of the Q1 GDP data, interest rates are impacting loan offtake, a flux F&O market affects trading, and more

Gokaldas takes Africa route to sidestep US duties

BUSINESS

Gokaldas takes Africa route to sidestep US duties

Atraco’s manufacturing units has duty free access to US, Europe and enjoy low labour costs

Moneycontrol Pro Panorama | The rise and rise of defence stocks

BUSINESS

Moneycontrol Pro Panorama | The rise and rise of defence stocks

In today's edition of Moneycontrol Pro Panorama: Unsecured retail lending putting pressure on NBFCs, market lessons for new-age traders, MSMEs need strategic push to flourish, it's India's time to shine, and more

Chart of the Day | Large caps hold sway over corporate profits

BUSINESS

Chart of the Day | Large caps hold sway over corporate profits

The contribution of large cap companies to aggregate sales and net profit of BSE 500 firms remains steady and similar to pre-COVID levels

CarTrade Tech’s focus on profitability at OLX soothes investor nerves

BUSINESS

CarTrade Tech’s focus on profitability at OLX soothes investor nerves

OLX has wide reach and can strengthen CarTrade’s automobile business

Moneycontrol Pro Panorama | Thermal power capex warms up

BUSINESS

Moneycontrol Pro Panorama | Thermal power capex warms up

In today's edition of Moneycontrol Pro Panorama: September may turn the market fortunes, rail freight traffic stutters, boycotting COP28 would cause more problems, a market to indulge your inner child, and more

Chart of the Day | Rail freight traffic growth decelerates to pre-COVID levels

BUSINESS

Chart of the Day | Rail freight traffic growth decelerates to pre-COVID levels

Total volumes grew just 1.5 percent in July 2023 indicating subdued business trends in logistics sector

Mega orders of Infosys, HCL should allay insourcing fears of IT investors

TRENDS

Mega orders of Infosys, HCL should allay insourcing fears of IT investors

Even as global enterprises develop technology capabilities, Indian IT vendors continue to find enough opportunities in the market

Sun Pharma's investors face a risk from India's unbranded generic drug push

BUSINESS

Sun Pharma's investors face a risk from India's unbranded generic drug push

Its large presence in India's branded generic drug market exposes it the most to a risk from trade generics. But other major pharma companies are at risk too

Soft summer season hits healthcare service providers

TRENDS

Soft summer season hits healthcare service providers

Fortis and Max Institute reported subdued sequential revenue growth in the June 2023 quarter

Moneycontrol Pro Panorama | Gland Pharma on a comeback trail 

BUSINESS

Moneycontrol Pro Panorama | Gland Pharma on a comeback trail 

In today’s edition of Moneycontrol Pro Panorama: MPC likely to vote for status quo, China's exclusion from global capital continues, Pakistan gears up for big political changes, make the most of the rising equity markets, and more

Impact of global inventory destocking goes beyond chemical sector

BUSINESS

Impact of global inventory destocking goes beyond chemical sector

As distributors liquidated excess inventories, sales volumes at Balkrishna Industries declined 19 percent in Q1 FY24

Green capex plans of Power Grid, NTPC look too ambitious

BUSINESS

Green capex plans of Power Grid, NTPC look too ambitious

While both companies forecast rapid addition of projects in the coming years, they don't match current capex trends. Investors should watch their return ratios and earnings

Moneycontrol Pro Panorama | Maruti Suzuki’s surprising U-turn   

BUSINESS

Moneycontrol Pro Panorama | Maruti Suzuki’s surprising U-turn   

In today’s edition of Moneycontrol Pro Panorama: Indian manufacturing a star performer, safeguard your business from GST frauds, unlike cooking - investing is a lived skill, India’s booming logistics sector, and more

What record plant availability at NTPC tells us about Indian power sector

BUSINESS

What record plant availability at NTPC tells us about Indian power sector

Thermal power plant availability improved as electricity demand softened in June 2023 quarter

Why Dr Lal PathLabs’ fat profit margins are bringing no cheer

BUSINESS

Why Dr Lal PathLabs’ fat profit margins are bringing no cheer

Business volumes lagged expectations as patient footfalls are largely unchanged in Q1 FY24 from year ago period

Moneycontrol Pro Panorama | Cipla, Dr Reddy’s deliver a pep pill for pharma stocks  

BUSINESS

Moneycontrol Pro Panorama | Cipla, Dr Reddy’s deliver a pep pill for pharma stocks  

In today’s edition of Moneycontrol Pro Panorama: New Delhi needs strategic approach towards China, Colgate brings cheers to investors, Manipur situation should be resolved soon, a safety net for the gig workers, and more

Sustained price hikes to aid profit margins of pharma companies

TRENDS

Sustained price hikes to aid profit margins of pharma companies

In the 12 months ending June 2023, price hikes contributed as much as half of the India pharma market growth

Midcap IT’s recovery optimism faces investor scrutiny

TRENDS

Midcap IT’s recovery optimism faces investor scrutiny

While frontline IT companies are uncertain about the near term outlook, Coforge, Persistent Systems and Mphasis sounded confident about sequential recovery

Rallis India’s results indicate tough times for agrochemical exporters 

BUSINESS

Rallis India’s results indicate tough times for agrochemical exporters 

While the export business is facing price erosion, delayed monsoon is feared to have weighed on product offtake in the June quarter

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347